Trends in the introduction of new drugs by pharmaceutical firms.

被引：0

作者：

DiMasi, JA ^{[1
]}

Healy, EM ^{[1
]}

Lasagna, L ^{[1
]}

机构：

[1] Tufts Univ, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PI34

引用

页码：145 / 145

页数：1

共 50 条

[1] New drug innovation and pharmaceutical industry structure: Trends in the output of pharmaceutical firms
DiMasi, JA
[J]. DRUG INFORMATION JOURNAL, 2000, 34 (04): : 1169 - 1194
[2] New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms
Joseph A. DiMasi
[J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (4): : 1169 - 1194
[3] The new European rurality: Strategies for small firms.
Stallmann, Judith I.
[J]. PAPERS IN REGIONAL SCIENCE, 2006, 85 (04) : 619 - 621
[4] CURRENT TRENDS IN INTRODUCTION OF NEW DRUGS
HAEN, PD
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1974, 16 (03) : 413 - 423
[5] The geography of multinational firms.
Santangelo, GD
[J]. JOURNAL OF EVOLUTIONARY ECONOMICS, 1999, 9 (03) : 401 - 402
[6] INTRODUCTION: Pharmaceutical Firms and the Right to Health
de Campos, Thana Cristina
Pogge, Thomas
[J]. JOURNAL OF LAW MEDICINE & ETHICS, 2012, 40 (02): : 183 - 187
[7] The origins of the international competitiveness of firms.
Aharoni, Y
[J]. JOURNAL OF ECONOMICS-ZEITSCHRIFT FUR NATIONALOKONOMIE, 2000, 71 (01): : 91 - 94
[8] LIABILITY: A NEW COST TRAP FOR ARCHITECTURAL/ENGINEERING AND CONSTRUCTION FIRMS.
Hayes, Glenn E.
Hundt, William G.
[J]. Cost Engineering (Morgantown, West Virginia), 1980, 22 (02): : 73 - 76
[9] Succession in Asian family firms.
Ram, Monder
[J]. INTERNATIONAL SMALL BUSINESS JOURNAL, 2006, 24 (04) : 428 - 430
[10] The autogenic welding in large firms.
Knappich, J
[J]. ZEITSCHRIFT DES VEREINES DEUTSCHER INGENIEURE, 1913, 57 : 1748 - 1751

← 1 2 3 4 5 →